Growth regulation of bovine retinal pericytes by transforming growth factor-beta2 and plasmin
- PMID: 10694890
Growth regulation of bovine retinal pericytes by transforming growth factor-beta2 and plasmin
Abstract
Purpose: Transforming growth factor -beta2 (TGF-beta2) is a predominant isoform of TGF-betas in the eye and plasmin is a peptidase with many functions. To better understand the pathogenesis of retinal microcirculation disorders, the effects of TGF-beta2 and plasmin on cultured bovine retinal pericytes were investigated.
Methods: Exogenous TGF-beta2 or plasmin was added to some cultures, DNA synthesis during cell cycle progression was investigated using [(3)H]thymidine incorporation. Anti-TGF-beta2 antibody was added to neutralize the effects of TGF-beta2. TGF-beta2 in the culture medium was measured using enzyme-linked immunosorbent assay (ELISA).
Results: Exogenous TGF-beta2 (10 pg to 100 ng/mL) suppressed DNA synthesis. Pericytes produced TGF-beta2. Anti-TGF-beta2 antibody neutralized TGF-beta2 and accelerated DNA synthesis, which shows that pericytes regulate their own cell cycle by action of the autocrine and/or paracrine system of TGF-beta2. Plasmin (0.2 to 0.5 U/mL) accelerated DNA synthesis in a dose-dependent manner, while addition of aprotinin, a protease inhibitor, counteracted this effect of plasmin. The concentration of TGF-beta2 in the culture medium decreased with the addition of plasmin. Simultaneous addition of both plasmin and anti-TGF-beta2 antibody accelerated DNA synthesis. High and low glucose concentrations of the culture medium did not affect DNA synthesis.
Conclusions: Our results suggest that TGF-beta2 and plasmin respectively decrease and increase DNA synthesis. In a retinal microcirculation disorder, they may play competitive roles in the cell cycle of pericytes.
Similar articles
-
TGF-beta2 in aqueous humor suppresses S-phase entry in cultured corneal endothelial cells.Invest Ophthalmol Vis Sci. 1999 Oct;40(11):2513-9. Invest Ophthalmol Vis Sci. 1999. PMID: 10509644
-
Failure of angiotensin II and insulin to stimulate transforming growth factor-beta1. Release from cultured bovine retinal pericytes.Diabetes Metab. 2002 Dec;28(6 Pt 1):499-503. Diabetes Metab. 2002. PMID: 12522331
-
IL-10 and antibodies to TGF-beta2 and PDGF inhibit RPE-mediated retinal contraction.Invest Ophthalmol Vis Sci. 2000 Apr;41(5):1210-6. Invest Ophthalmol Vis Sci. 2000. PMID: 10752962
-
Structure and activation of the large latent transforming growth factor-Beta complex.J Am Optom Assoc. 1998 Oct;69(10):643-8. J Am Optom Assoc. 1998. PMID: 9805445 Review.
-
A possible role of plasmin-dependent activation of TGF-β in cancer-associated thrombosis: Implications for therapy.Cancer Metastasis Rev. 2024 Nov 22;44(1):2. doi: 10.1007/s10555-024-10222-6. Cancer Metastasis Rev. 2024. PMID: 39576347 Free PMC article. Review.
Cited by
-
Biomarkers of Diabetic Retinopathy.Curr Diab Rep. 2016 Dec;16(12):125. doi: 10.1007/s11892-016-0812-9. Curr Diab Rep. 2016. PMID: 27778251 Review.